Kymera Therapeutics (KYMR)

P/S ratio as of August 2026 (TTM): 174

According to Kymera Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.81. At the end of 2026 the company had a P/S ratio of 124.

P/S ratio history for Kymera Therapeutics from 2020 to 2026

PS ratio at the end of each year

Year	P/S ratio	Change
2026	124	-16.49%
2025	148	169%
2024	55.2	207.01%
2023	18.0	-38.54%
2022	29.2	-34.72%
2021	44.8	-44.69%
2020	81.0

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
ORIC Pharmaceuticals ORIC	N/A	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Kymera Therapeutics (KYMR)

P/S ratio as of August 2026 (TTM): 174